Vol 55, No 2 (2024)
Editorial
Published online: 2024-04-30

open access

Page views 228
Article views/downloads 75
Get Citation

Connect on Social Media

Connect on Social Media

What’s new in chronic myelogenous leukemia and COVID-19?

Bartosz Puła1
Acta Haematol Pol 2024;55(2):59.

Abstract

Not available

References

  1. Lewandowski K. Asciminib a new player in treatment of TKI-resistant/intolerant chronic phase chronic myelogenous leukemia. Acta Haematol Pol. 2024; 55(2): 59.
  2. Warda H, Skórka K, Giannopoulos K. COVID-19 in patients with haematological malignancies. Acta Haematol Pol. 2024; 55(2): 73–89.
  3. Korycka-Wołowiec A, Góra-Tybor J, Treliński J, et al. Professor Euzebiusz Krykowski (3 January 1927–21 March 2024). Acta Hematol Pol. 2024; 55(2): 60–61.